title: CORONARY EFFECT OF FIBRATES ON PROTEINS AND ENZYMES WHICH HYDROLYZE TRIACYLGLYCEROLS.
abstract: Clofibric acid derivatives called fibrates, are quite commonly used lipid-lowering drugs, so it is necessary to know beneficial and adverse effects of these compounds on the body. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that benefits of four fibrates such as: bezafibrate, ciprofibrate, fenofibrate and gemfibrozil continue outweigh their risk in treatment of people with blood lipid disorders. According to recommendations of the CHMP fibrates should not be used as first-line drugs, except in patients with severe hypertriglyceridemia and patients who cannot use statins. In this paper, we focused on effect of clofibric acid derivatives on lipid metabolism, in particular on apoproteins and regulatory enzymes.
authors.forename: Renata
authors.initials: R
authors.lastname: Francik
authors.forename: Jadwiga
authors.initials: J
authors.lastname: Kryczyk
authors.forename: Sławomir
authors.initials: S
authors.lastname: Francik
mesh_terms: D000818:Animals; D002995:Clofibric Acid / Q000009:adverse effects* / Q000627:therapeutic use*; D003331:Coronary Vessels / Q000187:drug effects* / Q000201:enzymology*; D058607:Fibric Acids / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents; D014280:Triglycerides; D002995:Clofibric Acid